237 related articles for article (PubMed ID: 15477209)
41. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.
Calmels B; Lemarié C; Esterni B; Malugani C; Charbonnier A; Coso D; de Colella JM; Deconinck E; Caillot D; Viret F; Ladaique P; Lapierre V; Chabannon C
Transfusion; 2007 Jul; 47(7):1268-75. PubMed ID: 17581163
[TBL] [Abstract][Full Text] [Related]
42. Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation.
Ojeda-Uribe M; Sovalat H; Bourderont D; Brunot A; Marr A; Lewandowski H; Chabouté V; Peter P; Henon P
Cytotherapy; 2004; 6(6):571-83. PubMed ID: 15764022
[TBL] [Abstract][Full Text] [Related]
43. Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine.
Jacobs MR; Good CE; Fox RM; Roman KP; Lazarus HM
Transfusion; 2013 Nov; 53(11):2690-6. PubMed ID: 23461309
[TBL] [Abstract][Full Text] [Related]
44. Low infectious morbidity in patients with heavily pretreated hematological malignancies receiving autologous peripheral blood stem cell transplantation without antimicrobial prophylaxis.
Yeh SP; Chiu CF; Lo WJ; Lin CL; Hsueh CT; Liao YM; Shen YC
Ann Hematol; 2003 Jan; 82(1):24-9. PubMed ID: 12574960
[TBL] [Abstract][Full Text] [Related]
45. Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences.
Khuu HM; Cowley H; David-Ocampo V; Carter CS; Kasten-Sportes C; Wayne AS; Solomon SR; Bishop MR; Childs RM; Read EJ
Cytotherapy; 2002; 4(6):539-49. PubMed ID: 12568990
[TBL] [Abstract][Full Text] [Related]
46. [Improvement of routine works and quality control in mycobacterial laboratory].
Suzuki K; Higuchi T
Kekkaku; 2007 Mar; 82(3):217-27. PubMed ID: 17444126
[TBL] [Abstract][Full Text] [Related]
47. Factors influencing engraftment in autologous peripheral hematopoetic stem cell transplantation (PBSCT).
Ergene U; Cağirgan S; Pehlivan M; Yilmaz M; Tombuloğlu M
Transfus Apher Sci; 2007 Feb; 36(1):23-9. PubMed ID: 17292672
[TBL] [Abstract][Full Text] [Related]
48. The role of pegfilgrastim in mobilization of hematopoietic stem cells.
Kroschinsky F; Hölig K; Ehninger G
Transfus Apher Sci; 2008 Jun; 38(3):237-44. PubMed ID: 18490197
[TBL] [Abstract][Full Text] [Related]
49. Reduction in blood culture contamination rate by feedback to phlebotomists.
Gibb AP; Hill B; Chorel B; Brant R
Arch Pathol Lab Med; 1997 May; 121(5):503-7. PubMed ID: 9167605
[TBL] [Abstract][Full Text] [Related]
50. Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM.
Lioznov M; Dellbrügger C; Sputtek A; Fehse B; Kröger N; Zander AR
Bone Marrow Transplant; 2008 Jul; 42(2):121-8. PubMed ID: 18391988
[TBL] [Abstract][Full Text] [Related]
51. Overnight storage of autologous stem cell apheresis products before cryopreservation does not adversely impact early or long-term engraftment following transplantation.
Parkins MD; Bahlis N; Brown C; Savoie L; Chaudhry A; Russell JA; Stewart DA
Bone Marrow Transplant; 2006 Nov; 38(9):609-14. PubMed ID: 16980991
[TBL] [Abstract][Full Text] [Related]
52. Autologous gamete cryopreservation before hemopoietic stem cell transplantation.
Nagashima T; Muroi K; Kawano-Yamamoto C; Miyoshi T; Ohmine K; Toshima M; Miyazato A; Takatoku M; Nagai T; Mori M; Komatsu N; Ozawa K
Med Sci Monit; 2005 Mar; 11(3):CR91-4. PubMed ID: 15735568
[TBL] [Abstract][Full Text] [Related]
53. Blood culture contamination: a College of American Pathologists Q-Probes study involving 640 institutions and 497134 specimens from adult patients.
Schifman RB; Strand CL; Meier FA; Howanitz PJ
Arch Pathol Lab Med; 1998 Mar; 122(3):216-21. PubMed ID: 9823858
[TBL] [Abstract][Full Text] [Related]
54. Peripheral blood stem cell recovery following early termination of apheresis due to hypotension in a 4.8-kg infant.
Alex J; Bahl MJ; Schlueter AJ
J Clin Apher; 2009; 24(3):120-1. PubMed ID: 19253358
[TBL] [Abstract][Full Text] [Related]
55. High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy.
Ritchie S; Palmer S; Ellis-Pegler R
Intern Med J; 2007 Jan; 37(1):26-31. PubMed ID: 17199841
[TBL] [Abstract][Full Text] [Related]
56. Clinical impact of a new automated system employed for peripheral blood stem cell collection.
Del Fante C; Perotti C; Viarengo G; Bellotti L; Parisi C; Marchesi A; Tinelli C; Salvaneschi L
J Clin Apher; 2006 Dec; 21(4):227-32. PubMed ID: 16847939
[TBL] [Abstract][Full Text] [Related]
57. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact.
Lowder JN; Whelton P
Cytotherapy; 2003; 5(5):377-90. PubMed ID: 14578100
[TBL] [Abstract][Full Text] [Related]
58. Reduced hemoglobin on day of peripheral blood progenitor cell collection is associated with low graft content of vascular progenitors and increased toxicity after autologous hematopoietic stem cell transplantation.
Kasbia G; Al-Gahtani F; Tay J; Labonté L; Tinmouth A; Ramsay T; Gillingham A; Yang L; Halpenny M; Giulivi A; McDiarmid S; Huebsch L; Allan DS
Transfusion; 2008 Nov; 48(11):2421-8. PubMed ID: 18673346
[TBL] [Abstract][Full Text] [Related]
59. Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate.
Lemarie C; Calmels B; Malenfant C; Arneodo V; Blaise D; Viret F; Bouabdallah R; Ladaique P; Viens P; Chabannon C
Transfusion; 2005 May; 45(5):737-42. PubMed ID: 15847663
[TBL] [Abstract][Full Text] [Related]
60. Real-time process/quality control for HPC processing.
Arpagaus M; Leibundgut EO; Zbären K; Brunold C; Ischi E; Tobler A; Zwicky C
Cytotherapy; 2004; 6(5):505-13. PubMed ID: 15512917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
